Nanobiotix S.A (NANO) - Total Liabilities

Latest as of June 2025: €114.13 Million EUR ≈ $133.43 Million USD

Based on the latest financial reports, Nanobiotix S.A (NANO) has total liabilities worth €114.13 Million EUR (≈ $133.43 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore NANO cash flow conversion to assess how effectively this company generates cash.

Nanobiotix S.A - Total Liabilities Trend (2011–2024)

This chart illustrates how Nanobiotix S.A's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Nanobiotix S.A's assets to evaluate the company's liquid asset resilience ratio.

Nanobiotix S.A Competitors by Total Liabilities

The table below lists competitors of Nanobiotix S.A ranked by their total liabilities.

Company	Country	Total Liabilities
Techwing Inc KQ:089030	Korea	₩421.58 Billion
Msscorps Co Ltd TW:6830	Taiwan	NT$2.99 Billion
Abaxx Technologies Inc NEO:ABXX	Canada	CA$41.24 Million
Financial Street Holdings Co Ltd SHE:000402	China	CN¥87.72 Billion
Elite Advanced Laser Corp TW:3450	Taiwan	NT$5.44 Billion
HNA Technology Co Ltd A SHG:600751	China	CN¥2.30 Billion
Allegiant Travel Company NASDAQ:ALGT	USA	$3.16 Billion
Orchid Island Capital Inc. NYSE:ORC	USA	$10.30 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Nanobiotix S.A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Nanobiotix S.A.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.63	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.38	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.66	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	2.53	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nanobiotix S.A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nanobiotix S.A (2011–2024)

The table below shows the annual total liabilities of Nanobiotix S.A from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	€133.12 Million ≈ $155.63 Million	+39.04%
2023-12-31	€95.74 Million ≈ $111.93 Million	+10.28%
2022-12-31	€86.81 Million ≈ $101.49 Million	+15.78%
2021-12-31	€74.98 Million ≈ $87.66 Million	+17.96%
2020-12-31	€63.56 Million ≈ $74.31 Million	+9.38%
2019-12-31	€58.11 Million ≈ $67.94 Million	+81.88%
2018-12-31	€31.95 Million ≈ $37.36 Million	+135.90%
2017-12-31	€13.54 Million ≈ $15.84 Million	+4.16%
2016-12-31	€13.00 Million ≈ $15.20 Million	+20.33%
2015-12-31	€10.81 Million ≈ $12.63 Million	+60.38%
2014-12-31	€6.74 Million ≈ $7.88 Million	+58.29%
2013-12-31	€4.26 Million ≈ $4.98 Million	+27.93%
2012-12-31	€3.33 Million ≈ $3.89 Million	+67.40%
2011-12-31	€1.99 Million ≈ $2.32 Million	--

About Nanobiotix S.A

PA:NANO France Biotechnology

Market Cap

$1.62 Billion

€1.39 Billion EUR

Market Cap Rank

#7695 Global

#127 in France

Share Price

€28.72

Change (1 day)

+1.70%

52-Week Range

€3.01 - €33.50

All Time High

€33.50